Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-24
1994-10-11
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546212, C07D40914, A61K 31445
Patent
active
053547608
ABSTRACT:
The invention provides crystalline Tiagabine hydrochloride monohydrate, process for its preparation, compositions containing the same and its therapeutic use as anti-epileptic agent.
REFERENCES:
patent: 4721723 (1988-01-01), Barnes et al.
patent: 4910312 (1990-03-01), Pavia
patent: 5010090 (1991-04-01), Gronvald et al.
Pertwee et al., Neuropharmacology, vol. 27, No. 12, pp. 1265-1270 (1988).
Braestrup et al., Int. Congr. Ser.-Exerpta. Med. (Pharmacology), pp. 125-128 (1987).
Rustum et al., J. Chromatography, vol. 503, pp. 115-125 (1990).
Rekling et al., Br. J. Pharmacol. (1990), 99, pp. 103-106.
Cain Michael
Nielsen Peter
Patel Subhash
Petersen Henning
Agris Cheryl H.
Cintins Marianne M.
Novo Nordisk A S
Spivack Phyllis G.
Zelson Steve T.
LandOfFree
Crystalline Tiagabine monohydrate, its preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline Tiagabine monohydrate, its preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline Tiagabine monohydrate, its preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658805